Rein Piir

Biography

Rein Piir was appointed as Investor Relations Manager in 2016. In addition to his role as Investor Relations Manager at Oncopeptides, Rein holds investor relations positions at the life sciences companies Camurus AB and Alligator AB. Previous roles Rein has held include Head of Strategy at Alecta AB and Head of Analysis at Carnegie Investment Bank AB as well as Chief Financial Officer and Head of Investor Relations at Medivir AB. Rein also worked for several years at the international account anting firm PricewaterhouseCoopers. Rein currently holds directorships including at the Swedish life sciences company Integrative Research Laboratories Sweden. Rein Piir holds a B.Sc. Business Economics and Management from Uppsala University, Sweden. Born: 1958 Holdings in Oncopeptides: 2,500 shares (Indirectly owned through Piir & Partner AB) Other current positions: Chairman and CEO of Piir & Partner AB. Director of Integrative Research Laboratories Holding AB, Integrative Research Laboratories Sweden AB, L. E. Svensson Snickeri AB and Trygga Pengar i Mobilen Sverige AB. Vice President Investor Relations at Camurus AB.

Research Interest

Rein Piir holds a B.Sc. Business Economics and Management from Uppsala University, Sweden.